Tag Archives: journals

Journalists now can get access to Taylor & Francis journal articles

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

One of the biggest challenges to writing about medical research is actually getting your hands on the study.

Many of the larger or better-known journals, such as the JAMA group, NEJM, Pediatrics and Obstetrics & Gynecology, offer dedicated press access and helpful, well-staffed, responsive press offices who can send you a study quickly. Wiley and Elsevier both offer limited access to certain journals at certain times, though the process can be more complex and finicky depending on what you are covering. Continue reading

Full access to the Wiley Online Library added as member benefit

Pia Christensen

About Pia Christensen

Pia Christensen (@AHCJ_Pia) is the managing editor/online services for AHCJ. She manages the content and development of healthjournalism.org, coordinates AHCJ's social media efforts and edits and manages production of association guides, programs and newsletters.

The Association of Health Care Journalists has announced an enhanced partnership with global research and learning company John Wiley and Sons to provide professional journalists with access to the full collection of journals published on Wiley Online Library.

Wiley publishes on behalf of many of the world’s leading organizations dedicated to advancing health science. AHCJ members will be able to access 6 million articles from more than 1,500 journals, including Cochrane Library, Cancer, the Journal of the American Heart Association, and more.

See more …

How to think about impact factors: A journalist’s perspective

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

This is the second of two blog posts providing different perspectives on the value of considering a journal’s impact factor when considering whether to report on a study published in it. Today I feature an interview with AHCJ Vice President Ivan Oransky, M.D., who is co-founder of Retraction Watch and founder of Embargo Watch. He also is vice president and global editorial director at MedPage Today.

Oransky brings a journalist’s perspective to the importance of journal impact factors in evaluating the value of a study. My earlier post featured an interview with Hilda Bastian, Ph.D. who has background in research. Continue reading

How to think about impact factors: A researcher’s perspective

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Back in February, my tip sheet on the AHCJ site about evaluating the quality of a study mentioned that a journal’s impact factor may be considered in assessing whether to report on a study. While mentioned as one factor among many — and never a definitive one — it inspired a fair amount of debate on Twitter about the value, or lack thereof, of impact factors, especially given the rise of new open-access journals that haven’t been around long enough to have a high impact factor.

To add to the discussion, I reached out to two individuals with different perspectives— largely related to their differences in goals, values and needs in the spheres of research and journalism. Today’s post features a Q&A with Hilda Bastian, Ph.D., scientist, blogger at Absolutely Maybe on the Public Library of Science (PLOS) site and cartoonist at the wonderful and educational Statistically Funny site. Bastian also is a chief editor at PubMed Health and PubMed Commons, but her words here represent only her own views and not the views of any organization, including the National Institutes of Health. Bastian comes from a background of scientific research. Continue reading

Assessing a journal’s quality can help assess a study’s newsworthiness

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Photo: usabiomedlib via Flickr

Photo: usabiomedlib via Flickr

Perhaps you stumble onto an intriguing study that you haven’t seen covered and want to report on it. Or you receive a press release touting provocative findings that sound pretty astonishing … if they’re true. One potential indication of the paper’s significance and quality is the journal in which it was published.

Publication in a highly regarded journal is not a guarantee in itself that the paper is good – the blog Retraction Watch has hundreds of examples of that. In fact, one of the most famously retracted studies of all time – that of Andrew Wakefield’s attempt to link autism and vaccines in a small cases series – was published in The Lancet, one of the top medical journals in the U.K. (Ironically, that study continues to contribute to The Lancet’s impact factor because it’s the second-most-cited retracted paper as ranked by Retraction Watch.) Continue reading